Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Memorandum -- White House Cancer Moonshot Task Force
MEMORANDUM FOR THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIESSUBJECT.
Recipharm wrapping up its $105M deal for Indian sterile injectables maker Nitin
With cash in hand and an official nod from India, Sweden's Recipharm is just about ready to close on its deal to buy a majority stake in Indian sterile injectables maker Nitin Lifesciences.
Epilepsy drug may help against MS
Phenytoin, one of the oldest and most commonly prescribed epilepsy drugs, reduces damage from a complication of multiple sclerosis, according to a patient study.
Researchers tease apart a pathway certain cancer cells use to replicate
A new "player" in the way certain aggressive cancer cells may reproduce has been identified.
Edited stem cells offer hope of precision therapy for blindness
Using a new technology for repairing disease genes--the much-talked-about CRISPR/Cas9 gene editing--University of Iowa researchers working together with Columbia University Medical Center ophthalmolog...
FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Amgen (NASDAQ.
India's Mankind Pharma says it will build a plant in New Jersey
Like some of its competitors, India's Mankind Pharma figures that to grow, it needs manufacturing operations in the U.
Teva retrieves amphetamines over impurity concerns
Teva Pharmaceutical ($TEVA) has its hands full already with its $40.
Decoded: How a key defence protein leads to cancer
A team of Swiss and Russian scientists has decoded how a defence protein that fights viral infections in our body takes advantage of a weakness in our DNA replication process to induce mutations in ou...
Bachem brings peptide and small molecule generic APIs to DCAT
Bubendorf, Switzerland.
FDA expands Opdivo's melanoma approval to include BRAF-mutant patients
The US Food and Drug Administration (FDA) has once again expanded the indications for Bristol-Myers Squibb's (BMS) Opdivo (nivolumab) cancer drug.
Latin America registers more cases of zika as PAHO intensifies research
The Minister of Public Health in Ecuador, Margarita Guevara, confirmed 17 cases of the zika virus in the country, as reported Xinhua Sunday.
51
52
53
54
55
56
57
58
